ELEVANCE HEALTH INC (ELV) Stock Institutional Trading Activity


ELEVANCE HEALTH INC (ELV) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Brave Warrior Advisors, Eagle Capital Management, Baupost Group, Vulcan Value Partners, and Yacktman Asset Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2020Eagle Capital ManagementBuy909,9172,158,777$567,715
Q2 2020Yacktman Asset ManagementSell-10,287384,537$101,126
Q2 2020Sequoia Financial AdvisorsBuy421,441$379
Q2 2020Brave Warrior AdvisorsSell-103,999771,468$202,881
Q2 2020Vulcan Value PartnersBuy96,6631,826,490$480,330
Q2 2020First Eagle U.S. ValueBuy7,1542,159,483$567,901
Q1 2020Eagle Capital ManagementBuy1,248,8601,248,860$283,541
Q1 2020Yacktman Asset ManagementSell-243,288394,824$89,641
Q1 2020Sequoia Financial AdvisorsBuy1361,399$318
Q1 2020Thunderbird PartnersBuy6,869270,095$61,322
Q1 2020TCI Fund ManagementSell-3,138,793861,377$195,567
Q1 2020Brave Warrior AdvisorsBuy247,815875,467$198,766
Q1 2020Vulcan Value PartnersSell-135,4481,729,827$392,740
Q1 2020Viking Global InvestorsSell-1,275,5671,810,632$411,086
Q1 2020First Eagle U.S. ValueBuy148,5112,152,329$488,665
Q4 2019Vulcan Value PartnersBuy101,2021,865,275$563,369
Q4 2019Yacktman Asset ManagementSell-102,112638,112$192,729
Q4 2019Sequoia Financial AdvisorsBuy4581,263$381
Q4 2019Thunderbird PartnersBuy263,226263,226$79,502
Q4 2019Brave Warrior AdvisorsSell-10,745627,652$189,570
Q4 2019First Eagle U.S. ValueBuy340,8862,003,818$605,213
Q4 2019Viking Global InvestorsSell-787,2063,086,199$932,125
Q4 2019TCI Fund ManagementSell-80,4274,000,170$1,208,171
Q3 2019Yacktman Asset ManagementSell-1,109740,224$177,728
Q3 2019Hancock Classic ValueBuy312,438$585
Q3 2019Renaissance Technologies LLCBuy238,100514,073$123,429
Q3 2019Brave Warrior AdvisorsBuy638,397638,397$153,279
Q3 2019First Eagle U.S. ValueSell-174,4611,662,932$399,270
Q3 2019Vulcan Value PartnersBuy590,0371,764,073$423,554
Q3 2019Viking Global InvestorsSell-1,324,6013,873,405$930,005

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.